Related Experiment Video
Updated: Feb 16, 2026
04:44
Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
20.9K
Serum osteopontin and vitronectin levels in systemic sclerosis
Baris Gundogdu1, Servet Yolbas1, Musa Yilmaz2
1Department of Rheumatology, Faculty of Medicine, Firat University, Elazığ, Turkey.
Summary
Serum osteopontin levels are elevated in systemic sclerosis (SSc) and systemic lupus erythematosus (SLE) due to inflammation, not fibrosis. However, vitronectin levels decrease in SSc, potentially due to accumulation in fibrotic areas.
Area of Science:
- Biochemistry
- Immunology
- Rheumatology
Background:
- Osteopontin is a pro-fibrotic matricellular protein interacting with integrins like αvβ3.
- Vitronectin is a multifunctional glycoprotein and a known ligand for integrin αvβ3.
Purpose of the Study:
- To investigate serum osteopontin and vitronectin levels in patients with systemic sclerosis (SSc).
Main Methods:
- Serum levels of osteopontin, vitronectin, IL-6, and TGF-β were measured.
- Study included 86 SSc patients, 46 SLE patients, and 38 healthy controls (HC).
Main Results:
- Osteopontin levels were significantly higher in SSc and SLE patients compared to HC.
- Osteopontin did not correlate with disease activity or severity in SSc.
- Vitronectin levels were significantly lower in SSc patients compared to SLE and HC.
Conclusions:
- Elevated osteopontin in SSc may stem from inflammation rather than a specific fibrotic role.
- Decreased serum vitronectin in SSc, unlike in SLE, suggests potential accumulation in fibrotic tissues.
Related Concept Videos
01:22Connective Tissue Cell Types
4.3K
Connective tissue develops from the mesoderm of a developing embryo and consists of cells, fibers, and ground substance: a gel-like material containing large complexes of carbohydrates and proteins. Connective tissue was first identified as a separate tissue family in the 18th century, and Johannes Peter Muller coined the term connective tissue.
Fat cells (adipocytes), smooth muscle cells (myoblasts), and bone cells (osteoblasts) are some connective tissue cell types. Some immune system cells...
Fat cells (adipocytes), smooth muscle cells (myoblasts), and bone cells (osteoblasts) are some connective tissue cell types. Some immune system cells...
4.3K
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
619
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
619
01:20Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
355
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
355
01:27Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
586
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
586
01:21Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
462
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
462
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
696
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
696